Tenet Healthcare Corporation

Tenet Healthcare Corporation

THCยทNYSE

$164.84

+0.76%
HealthcareMedical - Care Facilities

Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb-salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, and telemedicine access services. In addition, it operates ambulatory surgery and urgent care centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals; and offers healthcare business process services in the areas of hospital and physician revenue cycle management, patient communications and engagement support, and value-based care solutions to hospitals, health systems, physician practices, employers, and other customers. As of February 09, 2022, the company operated 60 hospitals; and approximately 550 other healthcare facilities, including surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and other care sites and clinics. Tenet Healthcare Corporation was incorporated in 1975 and is headquartered in Dallas, Texas.

At a Glance

Live Snapshot
Market Cap$14.20B
EPS15.6100
P/E Ratio10.56
Earnings Date07/28/2026
3Y+11.0%
5Y+21.0%
10Y+9.0%
3Y+242.0%
5Y+253.0%
10Y-833.0%
3Y+227.0%
5Y+4.0%
10Y+534.0%
Tenet Healthcare Corporation

Tenet Healthcare Corporation Profit Bridge

THC ยท NYSE
Revenue21.31B
Cost of Goods Sold (3.78B)
Gross Profit17.53B
Operating Expenses (14.09B)
Operating Income3.44B
Interest Expense (821.00M)
Other Income/Expense-639.00M
Pretax Income2.80B
Income Tax (433.00M)
Net Income1.41B
Net Income
1.41B

Profitability Analysis

Gross Margin

82.3%

Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.

Operating Margin

16.1%

Healthy operating margins demonstrate effective cost control and strong business fundamentals.

Net Profit Margin

6.6%

Moderate profitability with room for improvement. Monitor interest expenses and tax efficiency.

Effective Tax Rate

15.5%

Moderate tax rate typical for most corporations. Represents standard tax burden on profits.

Profitability Insight

High margin compression: Large gap between gross and net margins suggests operational inefficiencies or heavy debt burden. Focus on expense management and deleveraging.

Tenet Healthcare Corporation Income Statement

THC โ€ข NYSE

Tenet Healthcare Corporation Income StatementDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009Dec 2008Dec 2007Dec 2006
REVENUE
21.3B
20.7B
20.5B
19.2B
19.5B
17.6B
18.5B
18.3B
19.2B
19.6B
18.6B
16.6B
11.1B
9.1B
8.7B
8.3B
9B
8.6B
8.1B
8.5B
GROSS PROFIT
(3.8B)
(12.5B)
(12.7B)
(12.1B)
(12.2B)
(11.4B)
(11.8B)
(11.7B)
(12.4B)
(12.5B)
(12B)
(10.7B)
(7.2B)
(5.8B)
(1.5B)
(1.5B)
(5.4B)
(5.3B)
(5B)
(5.3B)
17.5B
8.2B
7.8B
7B
7.3B
6.2B
6.7B
6.7B
6.8B
7.1B
6.7B
6B
3.9B
3.3B
7.1B
6.7B
3.6B
3.3B
3.1B
3.1B
OPERATING INCOME
(14.1B)
(2.3B)
(5.3B)
(4.7B)
(4.4B)
(4.2B)
(5.2B)
(5B)
(5.7B)
(5.9B)
(5.6B)
(5B)
(3.3B)
(2.6B)
(6.5B)
(6.1B)
(3.6B)
(3.3B)
(3.1B)
(3.1B)
(8.7B)
(8.8B)
(418M)
(412M)
(412M)
(403M)
(344M)
(0.0)
(0.0)
(315M)
(248M)
(234M)
(186M)
(156M)
(0.0)
(0.0)
(0.0)
(0.0)
(2.6B)
(2.5B)
3.4B
6B
2.5B
2.3B
2.9B
2B
1.5B
1.6B
1.1B
1.2B
1.1B
925M
663M
749M
653M
634M
596M
2.3B
2.2B
-732M
PRE-TAX INCOME
(821M)
(826M)
(901M)
(890M)
(923M)
(1B)
(985M)
(1B)
(1B)
(979M)
(912M)
(754M)
(474M)
(412M)
(375M)
(424M)
(445M)
(418M)
(439M)
(1.3B)
-821M
-826M
-901M
-890M
-923M
-1B
-985M
-1B
-1B
-979M
-912M
-754M
-474M
-412M
-375M
-424M
-445M
-418M
-419M
0.0
(5.4B)
-6.5B
(4.9B)
(4.3B)
(4B)
(3.8B)
(4.8B)
(5B)
(5.7B)
(5.6B)
(5.4B)
(4.8B)
(3.1B)
(0.0)
(2.4B)
(2.3B)
(3.6B)
(3.3B)
(451M)
(695M)
-639M
-708M
-893M
-988M
-983M
-1.3B
-1.2B
-1B
-1.2B
-999M
-933M
-778M
-821M
-415M
-489M
-476M
-391M
-2.2B
-2.3B
-345M
2.8B
5.2B
1.6B
1.3B
1.9B
671M
320M
629M
-101M
248M
144M
147M
-158M
334M
164M
158M
205M
54M
-96M
-1.1B
NET INCOME
(433M)
(1.2B)
(306M)
(344M)
(411M)
-97M
(160M)
(173M)
(219M)
(67M)
(68M)
(49M)
-65M
(125M)
(61M)
-977M
-23M
-25M
-61M
-262M
1.4B
3.2B
611M
411M
914M
399M
-215M
104M
-704M
-192M
-140M
12M
-134M
152M
82M
1.1B
187M
25M
-89M
-803M

SEC Filings

THC - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
8-K

8-K 2026

N/A

May 29, 2026
May 27, 2026
2026
10-Q

10-Q 2026 Q1

Q1

April 30, 2026
March 31, 2026
2026
8-K

8-K 2026

N/A

April 30, 2026
April 30, 2026
2026
DEF 14A

DEF 14A 2026

N/A

April 16, 2026
May 27, 2026
2026
8-K

8-K 2026

N/A

April 10, 2026
April 09, 2026
2026
8-K

8-K 2026

N/A

March 30, 2026
March 25, 2026
2026
10-K

10-K 2025 FY

FY

February 17, 2026
December 31, 2025
2025
8-K

8-K 2026

N/A

February 11, 2026
February 11, 2026
2026
8-K

8-K 2026

N/A

February 02, 2026
January 27, 2026
2026
8-K

8-K 2025

N/A

November 24, 2025
November 21, 2025
2025
Showing 1 to 10 of 665 filings